NASDAQ: INFI

Infinity Pharmaceuticals, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) between January 5, 2022 and July 24, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 16, 2023.

If you purchased Infinity securities during the Class Period and would like to join the action, please click “Join This Class Action.”

Class Period:January 5, 2022 through July 24, 2023
If you purchased Infinity securities during Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: “[b]y representing to shareholders that Infinity was moving forward on the MARIO-4 and MARIO-P studies for breast cancer and that Infinity had multiple partnership options, only to thereafter completely abandon that lead indication, was materially false and misleading. Infinity shareholders now know that Infinity’s lead candidates were being abandoned, Infinity is no longer partnering, Infinity is merging into a company with a lower market cap, and the merger candidate had recently abandoned its lead candidate, leaving Infinity with a pipeline that will take at least 6+ years to get a product on the market if the therapy even works.”

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:
Company Name: Infinity Pharmaceuticals, Inc.
Stock Symbol: INFI
Class Period: January 5, 2022 through July 24, 2023
Court: United States District Court District of Massachusetts

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top